AQST
AQST
NASDAQ · Pharmaceuticals

Aquestive Therapeutics Inc

$4.42
-0.57 (-11.42%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +486.0% upside
Low Target $17.61
Average Target $25.90
High Target $34.98
Current Price $4.42
Current
$4.42
Target
$25.90
$17.61 $25.90 avg $34.98
Scenario Analysis
Bear Case
$17.61
298.4%
Low target
Base Case
$25.90
+486.0%
Avg target
Bull Case
$34.98
+691.4%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$7.55
-41.5% from high
52-Week Low
$2.93
+50.9% from low
Target vs 52W High
$25.90
+243.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +19.1%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +24.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +32.1%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +41.0%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +168.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%